Connection
Wells Messersmith to Hematologic Diseases
This is a "connection" page, showing publications Wells Messersmith has written about Hematologic Diseases.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.072 |
|
|
|
-
Messersmith WA, Jimeno A, Ettinger D, Laheru D, Brahmer J, Lansey D, Khan Y, Donehower RC, Elsayed Y, Zannikos P, Hidalgo M. Phase I trial of weekly trabectedin (ET-743) and gemcitabine in patients with advanced solid tumors. Cancer Chemother Pharmacol. 2008 Dec; 63(1):181-8.
Score: 0.072